ArticleLeukemia2017

KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells.

J Etchin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.